Why the study?
Does clopidogrel plus aspirin improve safety and tolerability compared to ticlopidine plus aspirin in patients after coronary stenting?
Does clopidogrel plus aspirin improve safety and tolerability compared to ticlopidine plus aspirin in patients after coronary stenting?
Clopidogrel plus aspirin provides superior safety and tolerability compared to ticlopidine plus aspirin after coronary stenting, while maintaining comparable efficacy for preventing cardiac events.
Answers are grounded in this paper and cite their sources.
Supports clopidogrel plus aspirin as preferred post-stent dual therapy; reinforces safer alternative to ticlopidine with maintained efficacy.
The safety/tolerability of clopidogrel (plus aspirin) is superior to that of ticlopidine (plus aspirin) (P=0.005). The 300-mg loading dose was well tolerated, notably with no increased risk of bleeding. Secondary end point data are consistent with the hypothesis that clopidogrel and ticlopidine have comparable efficacy with regard to cardiac events after successful stenting.
No takes yet. Share an insight, caveat, or question.
Bertrand et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: